Blood and Urine Metabolic Biomarkers Monitor Short-term Dietary Changes
By LabMedica International staff writers Posted on 04 Nov 2019 |
Image: Researchers have identified several chemical signatures, detectable in blood and urine, that can accurately measure dietary intake (Photo courtesy of Medical Xpress).
Metabolites found in plasma and urine samples may serve as responsive biomarkers reflecting short-term changes in the habitual diet.
Unhealthy eating patterns have been linked to the increase in obesity and related chronic diseases such as diabetes worldwide. However, existing methods of assessing dietary intake in nutritional epidemiology rely on food frequency questionnaires or dietary records that are prone to bias and selective reporting.
To improve this situation, investigators at McMaster University (Hamilton, ON, Canada) sought to identify metabolites in readily accessible blood or urine samples that would reflect short-term changes in dietary intake. Measurement of those markers would be used to compare the foods provided to study participants to what they reported they had eaten.
Over the course of this study, metabolic phenotyping was performed on 42 healthy participants from the Diet and Gene Intervention (DIGEST) pilot study, a parallel two-arm randomized clinical trial that provided complete diets to all participants. Matching single-spot urine and fasting plasma specimens were collected at baseline, and then following two weeks of either a Prudent or Western diet with a weight-maintaining menu plan designed by a dietician. The Prudent diet was rich in fruits, vegetables, lean meats, and whole grains. The Western diet was rich in trans fats, processed foods, red meat, and sweetened beverages. Targeted and nontargeted metabolite profiling was conducted for two weeks using three complementary analytical platforms.
A modest reduction in systolic and diastolic blood pressure, and total cholesterol was reported for participants following the Prudent diet after two weeks as compared to the Western diet; however, dietary adherence relied on participant self-reporting, and food preparation methods were not standardized.
Overall, 3-methylhistidine and proline betaine concentrations increased in both plasma and urine samples after participants were assigned a Prudent diet with a corresponding decrease in the Western diet group. Similarly, creatinine-normalized urinary imidazole propionate, hydroxypipecolic acid, dihydroxybenzoic acid, and enterolactone glucuronide, as well as plasma ketoleucine and ketovaline increased with a Prudent diet after adjustments for age, sex, and BMI. In contrast, plasma myristic acid, linoelaidic acid, linoleic acid, alpha-linoleic acid, pentadecanoic acid, alanine, proline, carnitine, and deoxycarnitine, as well as urinary acesulfame K increased among participants following a Western diet. Most metabolites were also correlated to changes in the average intake of specific nutrients from self-reported diet records reflecting good adherence to assigned food provisions.
"We were able to detect short-term changes in dietary patterns which could be measured objectively," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "And it did not take long for these significant changes to become apparent. This has been a major issue in nutritional research and may be one of the main reasons for the lack of real progress in nutritional sciences and chronic disease prevention."
The dietary biomarker study was published in the October 9, 2019, online edition of the journal Nutrients.
Related Links:
McMaster University
Unhealthy eating patterns have been linked to the increase in obesity and related chronic diseases such as diabetes worldwide. However, existing methods of assessing dietary intake in nutritional epidemiology rely on food frequency questionnaires or dietary records that are prone to bias and selective reporting.
To improve this situation, investigators at McMaster University (Hamilton, ON, Canada) sought to identify metabolites in readily accessible blood or urine samples that would reflect short-term changes in dietary intake. Measurement of those markers would be used to compare the foods provided to study participants to what they reported they had eaten.
Over the course of this study, metabolic phenotyping was performed on 42 healthy participants from the Diet and Gene Intervention (DIGEST) pilot study, a parallel two-arm randomized clinical trial that provided complete diets to all participants. Matching single-spot urine and fasting plasma specimens were collected at baseline, and then following two weeks of either a Prudent or Western diet with a weight-maintaining menu plan designed by a dietician. The Prudent diet was rich in fruits, vegetables, lean meats, and whole grains. The Western diet was rich in trans fats, processed foods, red meat, and sweetened beverages. Targeted and nontargeted metabolite profiling was conducted for two weeks using three complementary analytical platforms.
A modest reduction in systolic and diastolic blood pressure, and total cholesterol was reported for participants following the Prudent diet after two weeks as compared to the Western diet; however, dietary adherence relied on participant self-reporting, and food preparation methods were not standardized.
Overall, 3-methylhistidine and proline betaine concentrations increased in both plasma and urine samples after participants were assigned a Prudent diet with a corresponding decrease in the Western diet group. Similarly, creatinine-normalized urinary imidazole propionate, hydroxypipecolic acid, dihydroxybenzoic acid, and enterolactone glucuronide, as well as plasma ketoleucine and ketovaline increased with a Prudent diet after adjustments for age, sex, and BMI. In contrast, plasma myristic acid, linoelaidic acid, linoleic acid, alpha-linoleic acid, pentadecanoic acid, alanine, proline, carnitine, and deoxycarnitine, as well as urinary acesulfame K increased among participants following a Western diet. Most metabolites were also correlated to changes in the average intake of specific nutrients from self-reported diet records reflecting good adherence to assigned food provisions.
"We were able to detect short-term changes in dietary patterns which could be measured objectively," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "And it did not take long for these significant changes to become apparent. This has been a major issue in nutritional research and may be one of the main reasons for the lack of real progress in nutritional sciences and chronic disease prevention."
The dietary biomarker study was published in the October 9, 2019, online edition of the journal Nutrients.
Related Links:
McMaster University
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans